The global virtual clinical trials market size is expected to reach USD 10.5 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.1% from 2020 to 2027. The need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.
There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical experiments. Virtual laboratory trials eliminate challenges posed by traditional laboratory experiments, for example, delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of the people favor a mobile experiment over traditional methods, and 80.0% of patients are more likely to participate in an experiment that uses mobile technology.
The current pandemic of COVID-19 is making the clinical trial industry change the way of conducting ongoing or upcoming lab experiments. The pandemic, for the first time in history, has resulted in the global disruption of traditional onsite lab experiments. Hence, the regulatory bodies such as the U.S. FDA, the European Medicines Agency (EMA), the National Institutes of Health (NIH), and China’s National Medical Products Administration, have issued guidelines related to the conduct of lab experiments during the outbreak of coronavirus, and are in complete support of incorporating virtual services.
Virtual clinical trials make use of monitoring devices, software apps, and online social engagement platforms to conduct every step of the research process, including patient recruitment, counseling, measuring clinical endpoints, informed consent, and adverse reactions. Telehealth, home care, and remote patient monitoring have been gaining momentum as a healthcare offering, and the COVID-19 pandemic is adding more horsepower to this initiative.
Request a Sample Copy of the Virtual Clinical Trials Market Research Report @ https://www.grandviewresearch.com/industry-analysis/virtual-clinical-trials-market/request/rs1
Virtual Clinical Trials Market Report Highlights
- The oncology segment alone held 25.0% of the market share in 2019. The increasing adoption of virtual experiments especially in oncology laboratory research for a diverse population is responsible for the growth.
- The interventional design segment accounted for the largest revenue share of 46.5% in 2019.
- North America held 49.7% of the market share in 2019. Favorable government initiatives and the presence of a large number of players in the U.S. offering advanced services are responsible for market growth.
- In Asia Pacific, the market is expected to witness the fastest CAGR of 6.2% over the forecast period owing to the increasing patient pool and cost-efficient services.
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/450563/ibb
Virtual Clinical Trials Market Segmentation
Grand View Research has segmented the global virtual clinical trials market based on study design, indication, and region:
Virtual Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 – 2027)
- Expanded Access
Virtual Clinical Trials Indication Outlook (Revenue, USD Million, 2016 – 2027)
Virtual Clinical Trials Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
List of Key Players of Virtual Clinical Trials Market
- ICON Plc
- PAREXEL International Corporation
- PRA Health Sciences
- Medable, Inc.
- LEO Innovation Lab
- Clinical Ink
Browse Related Reports @
Pain Management Devices Market: https://www.grandviewresearch.com/industry-analysis/pain-management-devices-market
Patient Monitoring Accessories Market: https://www.grandviewresearch.com/industry-analysis/patient-monitoring-accessories-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States